The effect of smoking on nontuberculous mycobacterial pulmonary disease and tuberculosis: a nationwide retrospective cohort study
- PMID: 39349592
- PMCID: PMC11442629
- DOI: 10.1038/s41598-024-72438-4
The effect of smoking on nontuberculous mycobacterial pulmonary disease and tuberculosis: a nationwide retrospective cohort study
Abstract
Although smoking is an established risk factor for Mycobacterial infection, the association between smoking and nontuberculous mycobacterial pulmonary disease (NTM-PD) remains unclear. We evaluated the association between smoking and NTM-PD and tuberculosis (TB) using a population-based South Korean nationwide cohort. Using the Korean National Health Insurance Database, we screened individuals over 20 years of age who underwent the national health screening program in 2009. Out of 3,774,308 eligible populations, we identified 2,964 and 26,112 cases of newly developed NTM-PD and TB, respectively. We used multivariate Cox proportional hazards models to estimate the adjusted hazard ratios (aHRs) of risk factors for NTM-PD and TB. The incidence rates for developing NTM-PD and TB were 0.08 and 0.68 per 1,000 person-years, respectively. Current smokers (aHR 0.63, 95% confidence interval [CI] 0.56-0.71) and current heavy smokers (≥ 20 pack-years, aHR 0.74, 95% CI 0.63-0.86) were at lower risk for NTM-PD development than never smokers. On the contrary, current smokers (aHR 1.19, 95% CI 1.15-1.23) and current heavy smokers (aHR 1.27, 95% CI 1.22-1.33) had a higher risk for TB development than never smokers. These trends were augmented if individuals started smoking before age 20 years. In subgroup analyses stratified by age, these trends were prominent in the 40-64 years age range. Current smoking was associated with a decreased risk of NTM-PD and increased risk of TB. These risks were augmented by early smoking initiation and in the middle age population.
Keywords: Age; NTM; Smoking; TB.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funder did not have any role in the design of the study, in the data collection, analysis, interpretation or in writing the manuscript.
Figures
Similar articles
-
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8. Respir Med. 2019. PMID: 31128614 Review.
-
Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.BMC Infect Dis. 2017 Jun 15;17(1):432. doi: 10.1186/s12879-017-2532-4. BMC Infect Dis. 2017. PMID: 28619015 Free PMC article.
-
Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.Ann Am Thorac Soc. 2019 Mar;16(3):341-347. doi: 10.1513/AnnalsATS.201806-366OC. Ann Am Thorac Soc. 2019. PMID: 30339468
-
Effect of comorbidities on mortality in patients with nontuberculous mycobacterial infection in Korea: National Health Insurance Service-National Sample Cohort data.Sci Rep. 2024 Oct 1;14(1):22815. doi: 10.1038/s41598-024-73768-z. Sci Rep. 2024. PMID: 39354035 Free PMC article.
-
Epidemiology of human pulmonary infection with nontuberculous mycobacteria.Clin Chest Med. 2002 Sep;23(3):553-67. doi: 10.1016/s0272-5231(02)00019-9. Clin Chest Med. 2002. PMID: 12370992 Review.
References
-
- Griffith, D. E. et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med.175, 367–416. 10.1164/rccm.200604-571ST (2007). - PubMed
-
- Dahl, V. N. et al. Global trends of pulmonary infections with nontuberculous mycobacteria: A systematic review. Int. J. Infect. Dis.125, 120–131. 10.1016/j.ijid.2022.10.013 (2022). - PubMed
-
- World Health Organization. Global tuberculosis report 2022. World Health Organizationhttps://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa... (2022).
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources